nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—ESR1—prostate cancer	0.154	0.662	CbGaD
Allylestrenol—ESR1—Estramustine—prostate cancer	0.087	0.248	CbGbCtD
Allylestrenol—CYP3A4—prostate cancer	0.0785	0.338	CbGaD
Allylestrenol—Quinestrol—Estramustine—prostate cancer	0.0565	0.154	CrCrCtD
Allylestrenol—ESR1—Estrone—prostate cancer	0.0561	0.16	CbGbCtD
Allylestrenol—ESR1—Ethinyl Estradiol—prostate cancer	0.05	0.143	CbGbCtD
Allylestrenol—Quinestrol—Estrone—prostate cancer	0.0449	0.123	CrCrCtD
Allylestrenol—Desogestrel—Ethinyl Estradiol—prostate cancer	0.0448	0.122	CrCrCtD
Allylestrenol—Quinestrol—Conjugated Estrogens—prostate cancer	0.0395	0.108	CrCrCtD
Allylestrenol—ESR1—Conjugated Estrogens—prostate cancer	0.0367	0.105	CbGbCtD
Allylestrenol—Norelgestromin—Ethinyl Estradiol—prostate cancer	0.035	0.0956	CrCrCtD
Allylestrenol—Quinestrol—Estradiol—prostate cancer	0.034	0.093	CrCrCtD
Allylestrenol—Quinestrol—Ethinyl Estradiol—prostate cancer	0.0332	0.0908	CrCrCtD
Allylestrenol—ESR1—Estradiol—prostate cancer	0.0322	0.0919	CbGbCtD
Allylestrenol—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.0289	0.0791	CrCrCtD
Allylestrenol—Norethindrone—Ethinyl Estradiol—prostate cancer	0.0232	0.0635	CrCrCtD
Allylestrenol—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0191	0.0521	CrCrCtD
Allylestrenol—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0183	0.0522	CbGbCtD
Allylestrenol—CYP3A4—Bicalutamide—prostate cancer	0.00962	0.0274	CbGbCtD
Allylestrenol—CYP3A4—Estramustine—prostate cancer	0.00894	0.0255	CbGbCtD
Allylestrenol—CYP3A4—Flutamide—prostate cancer	0.00797	0.0227	CbGbCtD
Allylestrenol—CYP3A4—Abiraterone—prostate cancer	0.00797	0.0227	CbGbCtD
Allylestrenol—Methyltestosterone—Prednisone—prostate cancer	0.0067	0.0183	CrCrCtD
Allylestrenol—CYP3A4—Cabazitaxel—prostate cancer	0.00589	0.0168	CbGbCtD
Allylestrenol—CYP3A4—Estrone—prostate cancer	0.00576	0.0164	CbGbCtD
Allylestrenol—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00513	0.0146	CbGbCtD
Allylestrenol—CYP3A4—Conjugated Estrogens—prostate cancer	0.00377	0.0107	CbGbCtD
Allylestrenol—CYP3A4—Mitoxantrone—prostate cancer	0.00343	0.00977	CbGbCtD
Allylestrenol—CYP3A4—Estradiol—prostate cancer	0.00331	0.00944	CbGbCtD
Allylestrenol—CYP3A4—Prednisone—prostate cancer	0.00285	0.00812	CbGbCtD
Allylestrenol—CYP3A4—Etoposide—prostate cancer	0.00216	0.00616	CbGbCtD
Allylestrenol—CYP3A4—Docetaxel—prostate cancer	0.00198	0.00564	CbGbCtD
Allylestrenol—CYP3A4—Doxorubicin—prostate cancer	0.00147	0.0042	CbGbCtD
Allylestrenol—Levonorgestrel—SRD5A1—prostate cancer	0.000378	0.136	CrCbGaD
Allylestrenol—Oxandrolone—AR—prostate cancer	0.000285	0.103	CrCbGaD
Allylestrenol—Desogestrel—SHBG—prostate cancer	0.000224	0.0806	CrCbGaD
Allylestrenol—CYP3A4—urine—prostate cancer	0.000221	0.187	CbGeAlD
Allylestrenol—Quinestrol—ESR1—prostate cancer	0.000202	0.0727	CrCbGaD
Allylestrenol—Gestodene—CYP3A5—prostate cancer	0.000193	0.0696	CrCbGaD
Allylestrenol—PGR—prostate gland—prostate cancer	0.000182	0.154	CbGeAlD
Allylestrenol—Ethynodiol—ESR1—prostate cancer	0.000166	0.0599	CrCbGaD
Allylestrenol—Desogestrel—ESR1—prostate cancer	0.000151	0.0545	CrCbGaD
Allylestrenol—ESR1—prostate gland—prostate cancer	0.000142	0.12	CbGeAlD
Allylestrenol—Norgestimate—ESR1—prostate cancer	0.000141	0.0509	CrCbGaD
Allylestrenol—PGR—epithelium—prostate cancer	0.000133	0.113	CbGeAlD
Allylestrenol—Levonorgestrel—SHBG—prostate cancer	0.000128	0.0462	CrCbGaD
Allylestrenol—Levonorgestrel—AR—prostate cancer	0.000112	0.0405	CrCbGaD
Allylestrenol—ESR1—epithelium—prostate cancer	0.000104	0.0885	CbGeAlD
Allylestrenol—Norethindrone—SHBG—prostate cancer	0.000104	0.0374	CrCbGaD
Allylestrenol—Methyltestosterone—SHBG—prostate cancer	9.85e-05	0.0355	CrCbGaD
Allylestrenol—ESR1—renal system—prostate cancer	9.68e-05	0.0821	CbGeAlD
Allylestrenol—Levonorgestrel—CYP19A1—prostate cancer	9.4e-05	0.0339	CrCbGaD
Allylestrenol—Levonorgestrel—ESR1—prostate cancer	8.65e-05	0.0312	CrCbGaD
Allylestrenol—Methyltestosterone—AR—prostate cancer	8.64e-05	0.0312	CrCbGaD
Allylestrenol—Norethindrone—CYP3A5—prostate cancer	8.26e-05	0.0298	CrCbGaD
Allylestrenol—PGR—testis—prostate cancer	8e-05	0.0678	CbGeAlD
Allylestrenol—Methyltestosterone—CYP19A1—prostate cancer	7.23e-05	0.0261	CrCbGaD
Allylestrenol—ESR1—testis—prostate cancer	6.26e-05	0.0531	CbGeAlD
Allylestrenol—PGR—lymph node—prostate cancer	5.8e-05	0.0492	CbGeAlD
Allylestrenol—Norethindrone—CYP2C19—prostate cancer	5.62e-05	0.0203	CrCbGaD
Allylestrenol—CYP3A4—renal system—prostate cancer	5.4e-05	0.0458	CbGeAlD
Allylestrenol—ESR1—lymph node—prostate cancer	4.54e-05	0.0385	CbGeAlD
Allylestrenol—Levonorgestrel—CYP3A4—prostate cancer	4.41e-05	0.0159	CrCbGaD
Allylestrenol—Norethindrone—CYP3A4—prostate cancer	3.58e-05	0.0129	CrCbGaD
Allylestrenol—Methyltestosterone—CYP3A4—prostate cancer	3.4e-05	0.0122	CrCbGaD
Allylestrenol—ESR1—Signaling Pathways—P4HB—prostate cancer	8.83e-06	0.000187	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VAV3—prostate cancer	8.72e-06	0.000185	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HIST1H2BG—prostate cancer	8.66e-06	0.000184	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TGFBR2—prostate cancer	8.6e-06	0.000182	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GRB7—prostate cancer	8.59e-06	0.000182	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PDE4D—prostate cancer	8.59e-06	0.000182	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NCOA1—prostate cancer	8.51e-06	0.00018	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ITPR1—prostate cancer	8.46e-06	0.000179	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	8.45e-06	0.000179	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HIST1H4H—prostate cancer	8.37e-06	0.000177	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—CREBBP—prostate cancer	8.36e-06	0.000177	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GNG5—prostate cancer	8.17e-06	0.000173	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—AR—prostate cancer	8.16e-06	0.000173	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—RXRA—prostate cancer	8.09e-06	0.000172	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1R—prostate cancer	8.09e-06	0.000171	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CBR1—prostate cancer	8.06e-06	0.000171	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CSAD—prostate cancer	8.06e-06	0.000171	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ADI1—prostate cancer	8.06e-06	0.000171	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PSAT1—prostate cancer	8.06e-06	0.000171	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GRHL1—prostate cancer	8.06e-06	0.000171	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TST—prostate cancer	8.06e-06	0.000171	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SERPINE1—prostate cancer	7.84e-06	0.000166	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LPL—prostate cancer	7.75e-06	0.000164	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PDGFRB—prostate cancer	7.68e-06	0.000163	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UGT2B17—prostate cancer	7.49e-06	0.000159	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GRHPR—prostate cancer	7.49e-06	0.000159	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CKMT2—prostate cancer	7.49e-06	0.000159	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UGT2B15—prostate cancer	7.49e-06	0.000159	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ITGB3—prostate cancer	7.49e-06	0.000159	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SIRT1—prostate cancer	7.44e-06	0.000158	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—VDR—prostate cancer	7.33e-06	0.000155	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ERBB3—prostate cancer	7.26e-06	0.000154	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FGFR2—prostate cancer	7.25e-06	0.000154	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTHLH—prostate cancer	7.11e-06	0.000151	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TGFBR1—prostate cancer	7.11e-06	0.000151	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PGAM2—prostate cancer	7.05e-06	0.000149	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—RFK—prostate cancer	7.05e-06	0.000149	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MBTPS1—prostate cancer	7.05e-06	0.000149	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NAGLU—prostate cancer	7.05e-06	0.000149	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SULT2B1—prostate cancer	7.05e-06	0.000149	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTM3—prostate cancer	7.05e-06	0.000149	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AOX1—prostate cancer	7.05e-06	0.000149	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKR1C3—prostate cancer	7e-06	0.000148	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PRKACB—prostate cancer	6.96e-06	0.000148	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TERT—prostate cancer	6.96e-06	0.000148	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PPP3CA—prostate cancer	6.79e-06	0.000144	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—THBS1—prostate cancer	6.79e-06	0.000144	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ERCC2—prostate cancer	6.7e-06	0.000142	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ANXA1—prostate cancer	6.69e-06	0.000142	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AMACR—prostate cancer	6.68e-06	0.000142	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP3A43—prostate cancer	6.68e-06	0.000142	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—DEGS1—prostate cancer	6.68e-06	0.000142	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NAT1—prostate cancer	6.68e-06	0.000142	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SRD5A2—prostate cancer	6.68e-06	0.000142	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—HIF1A—prostate cancer	6.66e-06	0.000141	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NR3C1—prostate cancer	6.6e-06	0.00014	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PRKCZ—prostate cancer	6.57e-06	0.000139	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LEP—prostate cancer	6.5e-06	0.000138	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CAV1—prostate cancer	6.44e-06	0.000137	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD17B1—prostate cancer	6.37e-06	0.000135	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—KDR—prostate cancer	6.37e-06	0.000135	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PARP1—prostate cancer	6.34e-06	0.000134	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGFR4—prostate cancer	6.34e-06	0.000134	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CALCA—prostate cancer	6.26e-06	0.000133	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ESR1—prostate cancer	6.21e-06	0.000132	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PPARA—prostate cancer	6.18e-06	0.000131	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL12—prostate cancer	6.12e-06	0.00013	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—BAD—prostate cancer	6.06e-06	0.000128	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—MYC—prostate cancer	6.05e-06	0.000128	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PIK3CG—prostate cancer	5.87e-06	0.000124	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APC—prostate cancer	5.87e-06	0.000124	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EGF—prostate cancer	5.8e-06	0.000123	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IRS1—prostate cancer	5.8e-06	0.000123	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CASP9—prostate cancer	5.76e-06	0.000122	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—B4GALT4—prostate cancer	5.68e-06	0.00012	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HPGD—prostate cancer	5.68e-06	0.00012	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GSK3B—prostate cancer	5.63e-06	0.000119	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PRKCQ—prostate cancer	5.58e-06	0.000118	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NGFR—prostate cancer	5.58e-06	0.000118	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—INS—prostate cancer	5.55e-06	0.000118	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MAP3K7—prostate cancer	5.52e-06	0.000117	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CREBBP—prostate cancer	5.44e-06	0.000115	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1—prostate cancer	5.37e-06	0.000114	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.34e-06	0.000113	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGF10—prostate cancer	5.3e-06	0.000112	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRB2—prostate cancer	5.25e-06	0.000111	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MTAP—prostate cancer	5.19e-06	0.00011	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.19e-06	0.00011	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MAP2K1—prostate cancer	5.19e-06	0.00011	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PIK3CD—prostate cancer	5.16e-06	0.000109	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VAV3—prostate cancer	5.12e-06	0.000109	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SERPINE1—prostate cancer	5.1e-06	0.000108	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.06e-06	0.000107	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.06e-06	0.000107	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TGFBR2—prostate cancer	5.05e-06	0.000107	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ITPR1—prostate cancer	4.96e-06	0.000105	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—MYC—prostate cancer	4.96e-06	0.000105	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FGF2—prostate cancer	4.94e-06	0.000105	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—CREBBP—prostate cancer	4.91e-06	0.000104	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NOS3—prostate cancer	4.87e-06	0.000103	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.83e-06	0.000102	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ACSL4—prostate cancer	4.83e-06	0.000102	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1R—prostate cancer	4.75e-06	0.000101	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—JAK2—prostate cancer	4.73e-06	0.0001	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UMPS—prostate cancer	4.63e-06	9.82e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PHGDH—prostate cancer	4.63e-06	9.82e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ARG2—prostate cancer	4.63e-06	9.82e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MDM2—prostate cancer	4.62e-06	9.79e-05	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SERPINE1—prostate cancer	4.6e-06	9.76e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ERBB2—prostate cancer	4.55e-06	9.66e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LPL—prostate cancer	4.55e-06	9.65e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LDHB—prostate cancer	4.54e-06	9.63e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PDGFRB—prostate cancer	4.51e-06	9.56e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PIK3CB—prostate cancer	4.49e-06	9.53e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.46e-06	9.45e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ITGB3—prostate cancer	4.4e-06	9.32e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CXCL8—prostate cancer	4.32e-06	9.16e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PDHA1—prostate cancer	4.3e-06	9.12e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TCN2—prostate cancer	4.3e-06	9.12e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—UCP3—prostate cancer	4.3e-06	9.12e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTA3—prostate cancer	4.3e-06	9.12e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ERBB3—prostate cancer	4.26e-06	9.04e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGFR2—prostate cancer	4.26e-06	9.02e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CDKN1B—prostate cancer	4.22e-06	8.94e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CASP3—prostate cancer	4.13e-06	8.76e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL2—prostate cancer	4.13e-06	8.75e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.11e-06	8.7e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.11e-06	8.7e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TERT—prostate cancer	4.09e-06	8.66e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CCND1—prostate cancer	4.02e-06	8.53e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CTNNB1—prostate cancer	3.98e-06	8.45e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTA4—prostate cancer	3.94e-06	8.35e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.94e-06	8.35e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—HIF1A—prostate cancer	3.91e-06	8.28e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MMP9—prostate cancer	3.91e-06	8.28e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CDKN1A—prostate cancer	3.89e-06	8.25e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTEN—prostate cancer	3.88e-06	8.23e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTA2—prostate cancer	3.84e-06	8.13e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LEP—prostate cancer	3.81e-06	8.09e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ABCG5—prostate cancer	3.79e-06	8.03e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.79e-06	8.03e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CAV1—prostate cancer	3.78e-06	8.01e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—KDR—prostate cancer	3.74e-06	7.92e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EP300—prostate cancer	3.7e-06	7.85e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTA1—prostate cancer	3.7e-06	7.85e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.66e-06	7.76e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTO1—prostate cancer	3.66e-06	7.76e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NAT2—prostate cancer	3.66e-06	7.76e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SRC—prostate cancer	3.6e-06	7.64e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—BAD—prostate cancer	3.55e-06	7.54e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LRP2—prostate cancer	3.51e-06	7.44e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.51e-06	7.44e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PLCB2—prostate cancer	3.51e-06	7.44e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VEGFA—prostate cancer	3.51e-06	7.44e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—STAT3—prostate cancer	3.47e-06	7.36e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PIK3CG—prostate cancer	3.44e-06	7.3e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APC—prostate cancer	3.44e-06	7.3e-05	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—AKT1—prostate cancer	3.44e-06	7.3e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—P4HB—prostate cancer	3.44e-06	7.29e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IRS1—prostate cancer	3.4e-06	7.21e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EGF—prostate cancer	3.4e-06	7.21e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.35e-06	7.1e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GSK3B—prostate cancer	3.3e-06	7e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.26e-06	6.92e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—INS—prostate cancer	3.26e-06	6.91e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MYC—prostate cancer	3.23e-06	6.84e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TGFB1—prostate cancer	3.22e-06	6.83e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MED12—prostate cancer	3.21e-06	6.8e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CREBBP—prostate cancer	3.19e-06	6.77e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GNG5—prostate cancer	3.18e-06	6.75e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—EGFR—prostate cancer	3.16e-06	6.69e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1—prostate cancer	3.15e-06	6.68e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NCOA3—prostate cancer	3.07e-06	6.5e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MAP2K1—prostate cancer	3.05e-06	6.46e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PIK3CD—prostate cancer	3.03e-06	6.42e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SERPINE1—prostate cancer	2.99e-06	6.35e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—KRAS—prostate cancer	2.98e-06	6.32e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HPGDS—prostate cancer	2.93e-06	6.2e-05	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—MYC—prostate cancer	2.91e-06	6.18e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.91e-06	6.16e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGF2—prostate cancer	2.9e-06	6.14e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NOS3—prostate cancer	2.86e-06	6.06e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ACHE—prostate cancer	2.84e-06	6.02e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTT1—prostate cancer	2.84e-06	6.02e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.8e-06	5.95e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—JAK2—prostate cancer	2.78e-06	5.89e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PIK3CA—prostate cancer	2.74e-06	5.81e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.73e-06	5.78e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PRKACB—prostate cancer	2.71e-06	5.75e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MDM2—prostate cancer	2.71e-06	5.75e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.69e-06	5.69e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ERBB2—prostate cancer	2.67e-06	5.67e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TP53—prostate cancer	2.65e-06	5.62e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PIK3CB—prostate cancer	2.64e-06	5.59e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NCOA2—prostate cancer	2.56e-06	5.43e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CXCL8—prostate cancer	2.54e-06	5.37e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CDKN1B—prostate cancer	2.48e-06	5.25e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.44e-06	5.18e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CASP3—prostate cancer	2.43e-06	5.14e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL6—prostate cancer	2.43e-06	5.14e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL2—prostate cancer	2.42e-06	5.14e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.38e-06	5.06e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CCND1—prostate cancer	2.36e-06	5.01e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NQO1—prostate cancer	2.36e-06	5e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CTNNB1—prostate cancer	2.34e-06	4.96e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TH—prostate cancer	2.32e-06	4.93e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MMP9—prostate cancer	2.29e-06	4.86e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CDKN1A—prostate cancer	2.28e-06	4.84e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTEN—prostate cancer	2.28e-06	4.83e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.26e-06	4.79e-05	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKT1—prostate cancer	2.24e-06	4.75e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GGT1—prostate cancer	2.19e-06	4.64e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EP300—prostate cancer	2.17e-06	4.61e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NCOA1—prostate cancer	2.16e-06	4.57e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.13e-06	4.51e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SRC—prostate cancer	2.11e-06	4.48e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VEGFA—prostate cancer	2.06e-06	4.37e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—RXRA—prostate cancer	2.05e-06	4.35e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—STAT3—prostate cancer	2.04e-06	4.32e-05	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—AKT1—prostate cancer	2.02e-06	4.28e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—COMT—prostate cancer	1.98e-06	4.19e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTP1—prostate cancer	1.97e-06	4.17e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ITPR1—prostate cancer	1.94e-06	4.1e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MYC—prostate cancer	1.89e-06	4.02e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TGFB1—prostate cancer	1.89e-06	4.01e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—EGFR—prostate cancer	1.85e-06	3.93e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TYMS—prostate cancer	1.83e-06	3.88e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTM1—prostate cancer	1.81e-06	3.83e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LPL—prostate cancer	1.77e-06	3.76e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—KRAS—prostate cancer	1.75e-06	3.71e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.71e-06	3.63e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ERCC2—prostate cancer	1.7e-06	3.6e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PIK3CA—prostate cancer	1.61e-06	3.41e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MTHFR—prostate cancer	1.6e-06	3.39e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPARA—prostate cancer	1.57e-06	3.32e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TP53—prostate cancer	1.56e-06	3.3e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CAV1—prostate cancer	1.47e-06	3.12e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL6—prostate cancer	1.42e-06	3.02e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.34e-06	2.85e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKT1—prostate cancer	1.31e-06	2.79e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—INS—prostate cancer	1.27e-06	2.69e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CREBBP—prostate cancer	1.24e-06	2.64e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.18e-06	2.5e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NOS3—prostate cancer	1.11e-06	2.36e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.03e-06	2.18e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTGS2—prostate cancer	1.02e-06	2.16e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTEN—prostate cancer	8.89e-07	1.88e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—EP300—prostate cancer	8.47e-07	1.8e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.27e-07	1.33e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKT1—prostate cancer	5.12e-07	1.09e-05	CbGpPWpGaD
